Michael Singer, MD, discusses the role of steroids, biomarkers, and second-generation therapies in diabetic macular edema management.
Michael A. Singer, MD
Advertisement
Articles by Michael A. Singer, MD
CAM encourages corneal healing in patients with ocular surface disease.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Modern Retina
1
Clinical Trials at the Summit 2026: First-time data, AI, and the next generation of retinal treatments
2
The Retina TL;DR with Dr. Weng: Clinical trials, career, and community with David A. Eichenbaum, MD, FASRS
3
Geographic atrophy: When lesion borders cannot be graded
4
FDA guidance to help accelerate cell and gene therapies
5